EUVIMEDEUVIMED entdecken
Crossref

Construction of Diversified Penta‐Spiro‐Heterocyclic and Fused‐Heterocyclic Frameworks with Potent Antitumor Activity

Qi Liu, Xuyi Liu, Yazhou Li, Yu Zhou, Linxiang Zhao, Xuewu Liang, Hong Liu

Chemistry – A European Journal · 26.09.2023 · 29 (54)

DOI: 10.1002/chem.202301553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 14.08.2023. Verfasst von Qi Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai, 201203, Chi…. Hauptthemen laut MEDLINE: Neoplasms, Rubiaceae. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Lingang Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple‐spiro/fused‐heterocyclic frameworks containing indazolone are structurally unique and represent a class of potentially dominant skeletons. In this work, we successfully fulfilled Rh(III)‐catalyst mediated substrate‐ and pH‐ controlled strategies to construct four novel types of complicated penta‐spiro/fused‐heterocyclic frameworks via C−H activation/[4+1] and [4+2] annulation cascades. This method had mild reaction conditions, a broad scope of substrates, moderate to good yields, and valuable applications, which could realize for the first time the generation of the novel di‐spiro‐heterocyclic and multiple fused‐heterocyclic products with unique structures. More importantly, novel spiro[cyclohexane‐indazolo[1,2‐ a ]indazole] scaffold constructed by this method exhibited potent antitumor activity against a variety of refractory solid tumors and hematological malignancies in vitro. Overall, our work provided new insights into the construction of complex and diverse multiple spiro/fused‐heterocyclic systems and offered novel valuable lead compounds for the discovery of antitumor drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsRubiaceaeCatalysis

Stichwörter der Autor:innen

C−H activation/ [4+1] and [4+2] annulationantitumorindazolonespiro/fused-heterocyclic frameworkssubstrate- and pH- controlled strategies

Autor:innen und Institutionen

  • State Key Laboratory of Drug Research Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai, 201203, China.
  • School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.

Förderung

  • National Natural Science Foundation of China
  • Lingang Laboratory

Zitieren

APA

Liu, Q., Liu, X., Li, Y., Zhou, Y., Zhao, L., Liang, X., & Liu, H. (2023). Construction of Diversified Penta‐Spiro‐Heterocyclic and Fused‐Heterocyclic Frameworks with Potent Antitumor Activity. Chemistry – A European Journal, 29(54). https://doi.org/10.1002/chem.202301553

Vancouver

Liu Q, Liu X, Li Y, Zhou Y, Zhao L, Liang X, et al. Construction of Diversified Penta‐Spiro‐Heterocyclic and Fused‐Heterocyclic Frameworks with Potent Antitumor Activity. Chemistry – A European Journal. 2023;29(54). doi:10.1002/chem.202301553

BibTeX
@article{Liu2023,
  author = {Liu, Qi and Liu, Xuyi and Li, Yazhou and Zhou, Yu and Zhao, Linxiang and Liang, Xuewu and Liu, Hong},
  title = {Construction of Diversified Penta‐Spiro‐Heterocyclic and Fused‐Heterocyclic Frameworks with Potent Antitumor Activity},
  journal = {Chemistry – A European Journal},
  year = {2023},
  volume = {29},
  number = {54},
  doi = {10.1002/chem.202301553}
}
Kostenlos starten →